Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects

Published:2008-01 Issue:3 Volume:9 Page:212-218
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Kirschbaum Katrin M.,Müller Matthias J.,Malevani Jaroslav,Mobascher Arian,Burchardt Carsten,Piel Markus,Hiemke Christoph

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.1080/15622970701361255

Reference21 articles.

1. The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

2. Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

3. Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives

4. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling;Psychiatry Research;2024-03

2. Evidence for Therapeutic Drug Monitoring of Atypical Antipsychotics;Prague Medical Report;2024

3. The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors;Biology Direct;2023-08-01

4. Clinical response to treatment with a partial dopamine agonist is related to changes in reward processing;Psychiatry Research;2023-08

5. Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations;Expert Opinion on Drug Metabolism & Toxicology;2023-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3